From: Mammalian microRNA: an important modulator of host-pathogen interactions in human viral infections
miRNAs | Targets | Actions |
---|---|---|
Hepatitis C virus | ||
 miR-21 | IFN1 | Suppress viral replication |
 miR-130a | HCV entry | |
 miR-21/miR-134/miR-320c/miR-483-5p | NFkB and PI3K-Akt | Inhibit NFkB and PI3K-Akt signaling pathway |
 miR-196 | HMOX1 | Increase replication |
 miR-279 | Lipid metabolism | Inhibit replication |
 miR-155 | wnt signaling | Immune defense against the virus |
Hepatitis B virus | ||
 miR-122 | upregulation of HMOX1 | Decrease virus level in cell |
 miR-501 | HBxIP |  |
 miR-372/373 | NFIB | Promotes replication |
 miR-155 | IFN1 | Suppress HBV disease pathogenesis |
Human Immunodeficiency Virus type 1 | ||
 miR-27b | Cyclin T1 | Prevent the activation of CD4+ cells |
 miR-155 | TLR3/Lymphocytes/DC | Reduces HIV-1 infection |
3′ UTR of HDFs; LEDGF/p75, ADAM10, NUP 153 | Decrease HIV replication | |
 miR-146a | CXCR4 | Prevents HIV-1 entry |
 miR-132 | MeCP-2 | Enhances HIV-1 infection |
 miR-217 and miR-34a | SIRT1 | Enhances HIV-1 tat-mediated trans-activation |
 miR-182 | NAMPT | Enhances HIV-1 tat-mediated trans-activation |
 miR-34a | PNUTS | Promotes HIV-1 transcription |
 miR-17/92 cluster and miR-20a | PCAF | Decrease susceptibility to HIV-1 infection |